Novavax, Inc. (NASDAQ:NVAX – Get Free Report)’s share price gapped down prior to trading on Friday . The stock had previously closed at $5.16, but opened at $5.02. Novavax shares last traded at $4.88, with a volume of 1,316,609 shares traded. Wall Street Analysts Forecast Growth Separately, StockNews.com upgraded Novavax from a “sell” rating to […]
This year’s rollout marks a definitive transition to a commercial market for the vaccines, which had previously been purchased by the U.S. government..
By Will Feuer Shares of Moderna and other makers of Covid-19 vaccines were dragged lower after rival Pfizer warned that it expects revenue from its Covid-19.
Novavax (NASDAQ:NVAX – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued on Friday. Separately, HC Wainwright reaffirmed a “buy” rating and set a $35.00 price objective on shares of Novavax in a report on Thursday, August 10th. Get Our […]
US Bancorp DE grew its position in Novavax, Inc. (NASDAQ:NVAX – Free Report) by 73.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,566 shares of the biopharmaceutical company’s stock after acquiring an additional 3,626 shares during the period. US […]